|
XPO5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.89539536580241E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.07549524841488E-11 |
| Normal-vs-Stage2 |
6.482300E-03 |
| Normal-vs-Stage3 |
1.63225999999517E-05 |
| Normal-vs-Stage4 |
4.962700E-03 |
| Stage1-vs-Stage2 |
3.118000E-01 |
| Stage1-vs-Stage3 |
1.781590E-01 |
| Stage1-vs-Stage4 |
9.673400E-01 |
| Stage2-vs-Stage3 |
7.743000E-01 |
| Stage2-vs-Stage4 |
3.435000E-01 |
| Stage3-vs-Stage4 |
3.947800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.81821224742862E-12 |
| Normal-vs-AfricanAmerican |
4.815700E-03 |
| Normal-vs-Asian |
3.228000E-01 |
| Caucasian-vs-AfricanAmerican |
1.265600E-01 |
| Caucasian-vs-Asian |
4.080800E-01 |
| AfricanAmerican-vs-Asian |
6.456100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.40459999964371E-07 |
| Normal-vs-Female |
3.86059995083343E-09 |
| Male-vs-Female |
9.856600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.5052399999993E-05 |
| Normal-vs-Extreme_Weight |
2.71740000501453E-08 |
| Normal-vs-Obese |
7.47609999462995E-08 |
| Normal-vs-Extreme_Obese |
5.295900E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.923600E-01 |
| Normal_Weight-vs-Obese |
5.820600E-03 |
| Normal_Weight-vs-Extreme_Obese |
6.189000E-01 |
| Extreme_Weight-vs-Obese |
4.082100E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.040600E-01 |
| Obese-vs-Extreme_Obese |
3.191800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.398100E-03 |
| Normal-vs-Age(41-60Yrs) |
1.382790E-04 |
| Normal-vs-Age(61-80Yrs) |
7.84210474336078E-11 |
| Normal-vs-Age(81-100Yrs) |
2.202100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.756000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.096240E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.633660E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.874010E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.118400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.784200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.23059999995934E-06 |
| Normal-VS-Type2 PRCC |
1.71989999997457E-06 |
| Normal-VS-KIRP CIMP |
4.444000E-02 |
| Normal-VS-Unclassified PRCC |
2.14799999999071E-05 |
| Type1 PRCC-VS-Type2 PRCC |
5.473400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.346000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.212000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.313000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.617800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.728400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.017040E-04 |
| Normal-vs-N1 |
6.666300E-02 |
| Normal-vs-N2 |
3.162200E-01 |
| N0-vs-N1 |
1.324950E-01 |
| N0-vs-N2 |
6.608400E-01 |
| N1-vs-N2 |
1.962230E-01 |
|
|
